The Business of Glaucoma By Steven D. Vold, MD
An analysis of early and recent research.
By Murray Johnstone, MD
Steroid Therapy and IOP
Along with the benefits of intravitreal injections and sustained-release implants comes the risk of steroid-induced ocular hypertension.
By Bradley P. Roth, MS, And Barbara Smit, MD, PhD
Gonioscopy-Assisted Transluminal Trabeculotomy: Blending Tradition With Innovation
The ab interno approach may prove to be the safest and most effective for glaucoma surgery.
By Aaron Barrett, MLS(ASCP), And Craig Chaya, MD
Satisfaction Rates With Electronic Health Records
The reviews are mediocre, but some physicians are enthusiastic.
By Jonathan S. Myers, MD
Selecting Glaucoma Medications
Insurance and other financial considerations
By Jacob T. Wilensky, MD
Point/Counterpoint: Is Cost a Viable Reason to Perform Glaucoma Surgery First? By Thomas Patrianakos, DO; Elizabeth Martin, MD; and Sarwat Salim, MD
Uveal Melanoma Masquerading as Pigment Dispersion Syndrome By Yijie (Brittany) Lin, MD, And Joseph F. Panarelli, MD
The Literature By Dipika B. Joshi, MD, and Tak Yee Tania Tai, MD
Neuroprotection in Glaucoma
Researchers continue to seek strategies and agents independent of IOP lowering that will protect neurons from apoptosis.
By Zakaria Bannur, MD, MSc(MEDICINE); Sushil Vasudevan, MBBS, MSurg(Ophth); Jonathan G. Crowston, FRCOphth, FRANZCO, PhD; and Ivan Goldberg, AM, MBBS, FRANZCO, FRACS
Micropulse Laser Trabeculoplasty After Previous Laser Trabeculoplasty By Tak Yee Tania Tai, MD
Will the Cost of Clinical Trials Quash Change in Glaucoma Treatment?
Financial burden compromises phase 3 trials and prolongs the approval of surgical devices.
By Alan L. Robin, MD
Topical Glaucoma Treatment and the Cornea
Alternative strategies may benefit patients with a compromised ocular surface.
By Adam C. Reynolds, MD
Vascular Considerations in Glaucoma Management
Evidence strongly suggests that ocular blood flow plays a role in glaucoma pathophysiology.
By Alon Harris, MS, PhD; Rehan Hussain, MD; Scott Wentz; and Brent Siesky, PhD
Genetics in Glaucoma Diagnosis and Management
Gene-based tests and therapies carry important implications for clinical practice.
By Inas F. Aboobakar, BS, and R. Rand Allingham, MD
Immunologic Considerations in Glaucoma Care
Innate and adaptive immune responses represent elusive but important components of the human glaucomatous process.
By Louis R. Pasquale, MD, and Meredith Gregory-ksander, PhD
Managing Systemic Disease in the Glaucoma Patient
Many systemic diseases may be correlated with glaucoma. Conversely, glaucoma treatments can affect a patient’s other systemic diseases.
By Jennifer Somers Weizer, MD
Current Approaches to Low-Tension Glaucoma
This challenging condition requires individualized care.
By Carla J. Siegfried, MD
Negotiating Language Barriers
Practitioners describe how they build trust through communication with patients who do not speak English.
By Rohit Varma, MD, MPH; Justin Schweitzer, OD; Darrell Wudunn, MD, PhD; and Walter O. Whitley, OD, MBA
Tube Coverage: Another Approach By Jonathan S. Myers, MD
Changing Paradigms in Glaucoma Care By Steven D. Vold, MD
The Role of 24-Hour IOP Monitoring in Glaucoma
Continuous monitoring would allow clinicians to develop a more complete IOP profile on which to base long-term treatment goals for patients.
By Leonard K. Seibold, MD; Kaweh Mansouri, MD, MPH; Jeffrey R. SooHoo, MD; and Malik Y. Kahook, MD
The Future of Noninvasive Surgeries to Enhance Aqueous Outflow
Sonic energy and the modified delivery of laser energy appear to be the next wave.
By Jeffrey A. Kammer, MD
Sidebar: Micropulse Laser Trabeculoplasty By Iqbal Ike K. Ahmed, MD, FRCSC
Sidebar: Pattern Scanning Laser Trabeculoplasty By Miho Nozaki, MD, PhD
The Jigsaw Effect
Refined perimetric analysis confirms that the brain coordinates bilateral glaucomatous neurodegeneration to optimize the surviving binocular visual field.
By William Eric Sponsel, MD
The Effects of Changing Demographics on Ophthalmology
An increase in life expectancy means more need for eye care as the population ages.
By Norbert Pfeiffer, MD, PhD
Does Blood Flow Measurement Have a Role in Glaucoma Care?
Advanced imaging technologies and therapeutic options make blood flow measurement a prime consideration in glaucoma monitoring.
By Ahmad A. Aref, MD; Yali Jia, PhD; and David Huang, MD, PhD
Implanting a Valved Tube Shunt By Soosan Jacob, MS, FRCS, DNB
Ruminations for the Voting Booth
Ophthalmologists need to research candidates running for office before voting in the 2014 midterm elections.
By Jeffrey J. Kimbell and Kenneth L. Hodge
The Literature By Sunju Park, MD, and Assumpta Madu, MD, PharmD, MBA
Arthur J. Sit, SM, MD By Arthur J. Sit, SM, MD
Could Glaucoma Be a Two-Pressure Disease?
Research on the effects of space flight on the ocular system may help reveal if cerebrospinal fluid pressure plays a role in the development of glaucoma and idiopathic intracranial hypertension.
By John P. Berdahl, MD
The Societal Costs of Blindness From Uncontrolled Glaucoma By Yvonne N. Covin, MD; Daniel Laroche, MD; and Mildred M. G. Olivier, MD
Advances in 24-Hour IOP Monitoring
This technology will lead to more personalized care for patients.
By Robert Chang, MD
Diurnal IOP Control: How Important Is It?
Many glaucoma experts agree that IOP variation is important to evaluating and managing patients with glaucoma.
By Sanjay Asrani, MD